Remsima (a Tumor Necrosis Factor (TNF) -α Inhibitor) induced hemolysis in a patient with Crohn's disease

登录注册会员服务联系我们

Remsima (a Tumor Necrosis Factor (TNF) -α Inhibitor) induced hemolysis in a patient with Crohn's disease - Case report

Published:2021-09 Issue: Volume:69 Page:102768
ISSN:2049-0801
Container-title:Annals of Medicine and Surgery
language:en
Short-container-title:Annals of Medicine and Surgery

Author:

AL-Ansari Rehab Y.,Khuraim Arwa AL.,Abdalla Leena,Hamid Hind,Zakary N.Y.

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference13 articles.

1. Inflammatory bowel disease;Wehkamp;Dtsch Arztebl Int,2016

2. Infliximab in treatment of Crohn's disease: the Milan experience;Ardizzone;Dig. Liver Dis.,2002

3. Safety of infliximab in Crohn's disease: a large single-center experience;Hamzaoglu;Inflamm. Bowel Dis.,2010

4. Meyler's side effects of drugs (sixteenth edition);The International Encyclopedia of Adverse Drug Reactions and Interactions,2016

5. The SCARE 2020 guideline: updating consensus surgical CAse REport (SCARE) guidelines;Agha;Int. J. Surg.,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune Haemolytic Anaemia as a Rare and Potentially Serious Complication of Crohn’s Disease in a 11-Year-Old Child—Case Report and Minireview;Children;2023-10-17

2. Piperacillin-tazobactam induced immune hemolytic anemia led to increased renal impairment and eventual death from multiple organ failure in a patient with hypertensive nephropathy: case report and literature review;BMC Nephrology;2023-06-14

3. Infliximab;Reactions Weekly;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP